Somareality Raises €3M+ for Eye-Tracking Cognitive Insights

Vienna-based DeepTech firm SOMAREALITY has successfully closed an oversubscribed Series A funding round, raising more than €3 million. This significant capital injection is earmarked to accelerate the company's mission of decoding human cognitive states through advanced eye-tracking analysis. The funding round saw participation from a robust investor syndicate, including lead investor Catalyst Romania, alongside existing backers MT-Lab, RDY Ventures, Moondust Ventures, and Gateway Ventures. This marks the 13th investment from Catalyst Romania Fund II, underscoring their confidence in the burgeoning field of cognitive analytics.

Founded in 2020 by Adrian Brodesser and Michel Varilek, SOMAREALITY leverages sophisticated algorithms to interpret eye movement patterns, translating them into real-time insights on cognitive load, attention, perception, and overall performance. The technology's hardware-agnostic nature and white-box approach allow for rapid, personalized cognitive assessments, requiring only brief data capture. This capability is particularly valuable in high-stakes sectors such as aviation and healthcare, where understanding operator cognitive states is paramount for safety and efficiency. The company has already demonstrated strong commercial traction, reporting over €2 million in B2B revenue since its first biomarker launch in 2024, with revenue more than doubling in 2025.

The strategic allocation of this new funding will focus on three core areas: expanding SOMAREALITY's established B2B market presence, supporting new longitudinal studies to track cognitive health and performance over extended periods, and crucially, enabling a significant push into the business-to-consumer (B2C) market. This expansion aims to democratize access to cognitive understanding, moving beyond laboratory settings to empower individuals with insights into their own mental processes. The company is also advancing its technology for on-chip deployment, facilitating seamless integration with wearable glasses.

Adrian Brodesser, co-founder of SOMAREALITY, highlighted the company's proven B2B success and the growing market demand for personalized health solutions and wearable technology. "With our presence in B2B and the trust put in us by our clients and partners, we’ve proven that cognitive insights based on eye tracking is here to stay," Brodesser stated. "Now, with persisting interest in personalised health as a whole and renewed interest in wearable eye tracking technology, we’re bringing our scientific underpinning to B2C and thereby to anyone who has always wanted to understand how their mind works but has never been able to outside of the lab."

Alin Stanciu, Partner at Catalyst Romania, expressed enthusiasm for SOMAREALITY's disruptive potential. "At Catalyst Romania, we aim to partner with companies that don’t just improve what already exists, but rethink entire industries – and SOMAREALITY is doing exactly that," Stanciu commented. "By turning eye-tracking data into real-time insights about how people think, they are opening up a new way to better understand the human mind, with impact far beyond current use cases." He further emphasized the potential to reshape sectors from healthcare to human performance, expressing strong confidence in the team's scientific expertise and ambition.

The market for neurotechnology and cognitive assessment tools is experiencing substantial growth, driven by advancements in AI, increased focus on mental well-being, and the proliferation of wearable devices. SOMAREALITY's approach, which integrates deep scientific understanding with practical, real-time application, positions it to capture a significant share of this expanding market. The company's ability to provide actionable insights from readily available eye-tracking data offers a compelling value proposition for both enterprise clients and individual consumers seeking to optimize cognitive function and well-being.